Novo Nordisk Pharma (Pvt.) Ltd

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 37,200 employees in 76 countries, and markets its products in more than 180 countries.Novo nordisk set up a high-tech insulin manufacturing plant in Tongi. The plant, the third set up by the company in Asia after China and India and it is a tie-up between the Novo Nordisk and Eskayef Bangladesh Ltd, a leading local pharmaceutical company. The Nordisk-Eskayef plant will manufacture over 5 million vials a year, maintaining the high-quality standards followed by Novo Nordisk across the world. Novo Nordisk enjoys more than 80 percent share in the insulin segment of diabetic care market in Bangladesh.

Top brands





Mixtard 30





Regular Insulin Human + Isophane Insulin Human







Actrapid





Insulin Human [rDNA]







NovoMix 30





Biphasic Insulin Aspart







NovoRapid





Insulin Aspart [Protamine Crystallised]







Ozempic





Semaglutide







Ryzodeg





Insulin Degludec + Insulin Aspart Premixed







Levemir Flexpen





Insulin Detemir









NovoPen 4





Insulin device & needle







Tresiba





Insulin Degludec







Norditropin Simplex





Somatropin







Victoza





Liraglutide







Fiasp FlexTouch





Insulin Aspart







NovoSeven





Coagulation Factor VIIa [Eptacog Alfa]








.btn-outline-teal { background: none; border: 1px solid teal; }
.btn-outline-teal:hover, .btn-outline-teal:active { background: teal; color: whitesmoke; }



View all brands